Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Ben Chang currently holds 0 shares of Rich Pharmaceuticals, Inc. (RCHA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ben Chang has been a net neutral trader of RCHA stock. They have purchased $0 and sold $0 worth of shares.
Ben Chang's most recent insider trade was on Mar 30, 2017, when they sold 0 shares at $0.00 per share.
Ben Chang serves as Executive at Rich Pharmaceuticals, Inc. (RCHA). They have executed 3 insider transactions totaling $0 over their tenure at the company.
Ben Chang holds the position of Executive at Rich Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 12 years and currently hold a stake valued at $0.
Ben Chang has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Ben Chang was on Mar 30, 2017, when they purchased $0 worth of RCHA shares. This transaction involved 0 shares at N/A per share.
Ben Chang currently owns 0 shares of Rich Pharmaceuticals, Inc. (RCHA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Ben Chang's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Ben Chang has 3 Form 4 filings on record as an insider at Rich Pharmaceuticals, Inc..
Set alerts for Ben Chang and 40,000+ other insiders.